139 related articles for article (PubMed ID: 34275119)
21. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer.
Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
[TBL] [Abstract][Full Text] [Related]
22. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
[TBL] [Abstract][Full Text] [Related]
23. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.
Gallmeier E; Schäfer C; Moubarak P; Tietz A; Plössl I; Huss R; Göke B; Wagner AC
J Cell Physiol; 2005 Apr; 203(1):209-16. PubMed ID: 15493010
[TBL] [Abstract][Full Text] [Related]
24. Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.
Shang AQ; Wu J; Bi F; Zhang YJ; Xu LR; Li LL; Chen FF; Wang WW; Zhu JJ; Liu YY
Cancer Biol Ther; 2017 May; 18(5):314-322. PubMed ID: 28448787
[TBL] [Abstract][Full Text] [Related]
25. Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2.
Sakamoto E; Hato F; Kato T; Sakamoto C; Akahori M; Hino M; Kitagawa S
J Leukoc Biol; 2005 Jul; 78(1):301-9. PubMed ID: 15845643
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the SOCS1-JAK2-STAT3 Signaling Pathway Confers Neuroprotection in Rats with Ischemic Stroke.
Wang XL; Qiao CM; Liu JO; Li CY
Cell Physiol Biochem; 2017; 44(1):85-98. PubMed ID: 29130998
[TBL] [Abstract][Full Text] [Related]
27. A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts.
Ilangumaran S; Finan D; La Rose J; Raine J; Silverstein A; De Sepulveda P; Rottapel R
J Immunol; 2002 Nov; 169(9):5010-20. PubMed ID: 12391216
[TBL] [Abstract][Full Text] [Related]
28. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
[TBL] [Abstract][Full Text] [Related]
29. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
Song MM; Shuai K
J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
[TBL] [Abstract][Full Text] [Related]
30. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
[TBL] [Abstract][Full Text] [Related]
31. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
[TBL] [Abstract][Full Text] [Related]
32. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
33. Interferon-γ stimulates human follicular dendritic cell-like cells to produce prostaglandins via the JAK-STAT pathway.
Kim J; Yoon Y; Jeoung D; Kim YM; Choe J
Mol Immunol; 2015 Aug; 66(2):189-96. PubMed ID: 25818476
[TBL] [Abstract][Full Text] [Related]
34. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma.
Ehrentraut S; Schneider B; Nagel S; Pommerenke C; Quentmeier H; Geffers R; Feist M; Kaufmann M; Meyer C; Kadin ME; Drexler HG; MacLeod RA
Oncotarget; 2016 Jun; 7(23):34201-16. PubMed ID: 27144517
[TBL] [Abstract][Full Text] [Related]
35. Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway.
Jeon SB; Yoon HJ; Chang CY; Koh HS; Jeon SH; Park EJ
J Immunol; 2010 Dec; 185(11):7037-46. PubMed ID: 20980634
[TBL] [Abstract][Full Text] [Related]
36. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways.
Wu L; Qian C; Zhang W; Shi M; Chen X; Wang Y; Lin F
Phytomedicine; 2023 Jul; 116():154846. PubMed ID: 37172479
[TBL] [Abstract][Full Text] [Related]
37. Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling.
Gingras S; Parganas E; de Pauw A; Ihle JN; Murray PJ
J Biol Chem; 2004 Dec; 279(52):54702-7. PubMed ID: 15491990
[TBL] [Abstract][Full Text] [Related]
38. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
39. Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.
DiGiandomenico A; Wylezinski LS; Hawiger J
Sci Signal; 2009 Jul; 2(80):ra37. PubMed ID: 19622834
[TBL] [Abstract][Full Text] [Related]
40. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells.
Monni R; Santos SC; Mauchauffe M; Berger R; Ghysdael J; Gouilleux F; Gisselbrecht S; Bernard O; Penard-Lacronique V
Oncogene; 2001 Feb; 20(7):849-58. PubMed ID: 11314018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
